Related Experiment Video
Updated: Aug 4, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial cardiomyopathy and incident ischemic stroke risk: a systematic review and meta-analysis
Jiahuan Guo1, Dandan Wang1, Jiaokun Jia1
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Fanyang Street 119, Beijing, 100070, China.
Insights
Atrial cardiomyopathy markers like P-terminal force in V1, P-wave area, left atrial diameter, and NT-proBNP can predict ischemic stroke risk. These markers aid in stratifying stroke risk for better patient management.
Area of Science:
- Cardiology
- Neurology
- Biomarker Research
Background:
- Atrial cardiomyopathy is increasingly recognized for its role in thrombosis and ischemic stroke.
- Quantifying atrial cardiomyopathy markers is crucial for predicting ischemic stroke risk.
Approach:
- Systematic review and meta-analysis of 25 longitudinal cohort studies.
- Involved 262,504 individuals, analyzing electrocardiographic, structural, functional, and serum biomarkers.
- Searched PubMed, Embase, and Cochrane Library for relevant studies.
Key Points:
- P-terminal force in V1 (PTFV1), P-wave area, and left atrial (LA) diameter are independent predictors of ischemic stroke.
- LA reservoir strain and N-terminal pro-brain natriuretic peptide (NT-proBNP) also show significant associations with stroke risk.
- Various markers, including PTFV1 (HR 1.29), max P-wave area (HR 1.14), LA diameter (HR 1.39), LA reservoir strain (HR 0.88), and NT-proBNP (HR 2.37), demonstrated predictive value.
Conclusions:
- Electrocardiographic, serum, and LA structural/functional markers of atrial cardiomyopathy are valuable for risk stratification.
- These markers can identify individuals at higher risk of incident ischemic stroke.
- Utilizing these biomarkers can improve the prediction and management of ischemic stroke.
Background And Purpose:
Growing evidence suggests that atrial cardiomyopathy may play an essential role in thrombosis and ischemic stroke. The aim of this systematic review and meta-analysis was to quantify the values of cardiomyopathy markers for predicting ischemic stroke risk.
Methods:
PubMed, Embase, and the Cochrane Library were searched for longitudinal cohort studies evaluating the association between cardiomyopathy markers and incident ischemic stroke risk.
Results:
We included 25 cohort studies examining electrocardiographic, structural, functional, and serum biomarkers of atrial cardiomyopathy involving 262,504 individuals. P-terminal force in the precordial lead V1 (PTFV1) was found to be an independent predictor of ischemic stroke as both a categorical variable (HR 1.29, CI 1.06-1.57) and a continuous variable (HR 1.14, CI 1.00-1.30). Increased maximum P-wave area (HR 1.14, CI 1.06-1.21) and mean P-wave area (HR 1.12, CI 1.04-1.21) were also associated with an increased risk of ischemic stroke. Left atrial (LA) diameter was independently associated with ischemic stroke as both a categorical variable (HR 1.39, CI 1.06-1.82) and a continuous variable (HR 1.20, CI 1.06-1.35). LA reservoir strain independently predicted the risk of incident ischemic stroke (HR 0.88, CI 0.84-0.93). N-terminal pro-brain natriuretic peptide (NT-proBNP) was also associated with incident ischemic stroke risk, both as a categorical variable (HR 2.37, CI 1.61-3.50) and continuous variable (HR 1.42, CI 1.19-1.70).
Conclusion:
Atrial cardiomyopathy markers, including electrocardiographic markers, serum markers, LA structural and functional markers, can be used to stratify the risk of incident ischemic stroke.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiomyopathy I: Introduction and Classification
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Coronary Artery Disease II: Pathophysiology

